How much funding has Sapphiros raised?

Sapphiros has raised $30.0M in total funding, most recently a Series B round.

Who are Sapphiros's investors?

Sapphiros's investors include OraSure Technologies, KKR.

Where is Sapphiros headquartered?

Sapphiros is headquartered in Boston, Massachusetts, United States.

What industry is Sapphiros in?

Sapphiros operates in Biotech, Healthcare.

How many employees does Sapphiros have?

Sapphiros has 51-200 employees.

Sapphiros

Boston, United States · Founded 2021 · $30.0M raised

Biotech

Healthcare

Headquarters: Boston, Massachusetts
Employees: 51–200
Founded: 2021
Business Model: B2B

Website: sapphiros.com
Total Funding: $30.0M
Last Round: $30.0M Series BJan 2024
Rounds: 2

About

Sapphiros is a Boston-based platform company formed in 2021 in partnership with KKR and Namal Nawana to invest in and operate a portfolio of next-generation diagnostic technologies. The company focuses on accessible, affordable, and scalable health technology spanning infectious disease testing, point-of-care diagnostics, and public health emergency preparedness. Sapphiros has partnered with organizations including Roche, BARDA, the Gates Foundation, and the NIH, and holds a 5-billion-unit annual manufacturing capacity.

Summary

Sapphiros is a Biotech company based in Boston, United States, founded in 2021. It has raised $30.0M in total across 2 rounds, most recently a $30.0M Series B round in Jan 2024. Investors include OraSure Technologies and KKR.